Chris Delaney is the Founder and Chief Executive of Insignia Health. Insignia partners with leading health systems, hospitals, insurers and pharmaceutical companies around the world to license and implement the Patient Activation Measure® (PAM®) and related activation-based health solutions. PAM allows these organizations to better identify and treat individuals based upon their ability to manage their own health.
PAM was developed at the University of Oregon and has been validated by more than 600 independent scientific research studies over the past two decades. It is the cornerstone of a suite of Insignia programs designed to help individuals become more active self-managers of their health and healthcare.
Prior to Insignia, Chris co-founded the Sequoi Group, a consultancy that advised health plans on member engagement strategies and programs. Chris was also Chief Marketing Officer at Definity Health, which pioneered the consumer-driven healthcare model and account-based HSA and HRA health benefit designs, as well as a host of consumer health innovations centered on personalization. He has served as an advisor to various healthcare organizations, including Healthline, a leading health website and pioneer in medically-guided intelligent online search and the New England Healthcare Institute (NEHI) working group on medication adherence.
Chris holds a Masters Degree in Business Administration from the University of Minnesota’s Carlson School of Management and a Bachelor of Arts degree in Psychology from Occidental College.